Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Change in Accured Expenses (2016 - 2025)

Chemours (CC) has 12 years of Change in Accured Expenses data on record, last reported at -$95.0 million in Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 163.89% year-over-year to -$95.0 million; the TTM value through Dec 2025 reached -$3.0 million, up 99.55%, while the annual FY2025 figure was -$3.0 million, 99.55% up from the prior year.
  • Change in Accured Expenses reached -$95.0 million in Q4 2025 per CC's latest filing, down from $22.0 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $401.0 million in Q2 2023 and bottomed at -$644.0 million in Q2 2024.
  • Average Change in Accured Expenses over 5 years is $19.3 million, with a median of $21.0 million recorded in 2021.
  • Peak YoY movement for Change in Accured Expenses: skyrocketed 284.09% in 2021, then crashed 1695.0% in 2022.
  • A 5-year view of Change in Accured Expenses shows it stood at $20.0 million in 2021, then plummeted by 1695.0% to -$319.0 million in 2022, then soared by 94.36% to -$18.0 million in 2023, then crashed by 100.0% to -$36.0 million in 2024, then plummeted by 163.89% to -$95.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Accured Expenses were -$95.0 million in Q4 2025, $22.0 million in Q3 2025, and $75.0 million in Q2 2025.